Repligen | RGEN - 売上総利益





売上総利益 変化する 日付
Agilent USD 990M 44M 2026-03
Align Technology USD 757.43M 20.84M 2026-06
Bio Techne USD 208.29M 17.01M 2026-03
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Bruker USD 379.8M 69.4M 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Danaher USD 3.61B 20M 2026-06
Dentsply International USD 427M 16M 2026-03
General Electric Aerospace USD 4.46B 220M 2026-06
Henry Schein USD 1.07B 7M 2026-03
Illumina USD 770M 49M 2026-06
IQVIA Holdings USD 1.07B 52M 2026-03
Mettler Toledo International USD 555.82M 119.62M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Pfizer USD 11.04B 1.24B 2026-03
Repligen USD 108.28M 4.45M 2026-03
Revvity USD 387.66M 34M 2026-03
Standard Biotools USD 11.31M 74K 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Waters USD 542M 15.42M 2026-03
West Pharmaceutical Services USD 296.4M 7.5M 2026-03